OM
Opaleye Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-62,501
| Closed | -$1.39M | – | 44 |
|
|
2025
Q1 | $1.39M | Buy |
+62,501
| New | +$1.39M | 0.31% | 38 |
|
|
2024
Q1 | – | Sell |
-37,500
| Closed | -$640K | – | 57 |
|
|
2023
Q4 | $640K | Buy |
+37,500
| New | +$640K | 0.17% | 46 |
|
|
2022
Q3 | – | Sell |
-814,250
| Closed | -$7.89M | – | 47 |
|
|
2022
Q2 | $7.89M | Sell |
814,250
-298,250
| -27% | -$2.89M | 3.56% | 9 |
|
|
2022
Q1 | $11.1M | Buy |
1,112,500
+87,500
| +9% | +$870K | 3.43% | 10 |
|
|
2021
Q4 | $12.1M | Sell |
1,025,000
-285,000
| -22% | -$3.35M | 2.56% | 12 |
|
|
2021
Q3 | $14.9M | Buy |
1,310,000
+154,800
| +13% | +$1.76M | 2.79% | 11 |
|
|
2021
Q2 | $16.1M | Buy |
1,155,200
+834,274
| +260% | +$11.6M | 2.67% | 11 |
|
|
2021
Q1 | $5.94M | Buy |
320,926
+96,826
| +43% | +$1.79M | 0.87% | 34 |
|
|
2020
Q4 | $3.96M | Sell |
224,100
-113,900
| -34% | -$2.01M | 0.52% | 41 |
|
|
2020
Q3 | $8.78M | Sell |
338,000
-6,500
| -2% | -$169K | 1.72% | 25 |
|
|
2020
Q2 | $8.78M | Buy |
+344,500
| New | +$8.78M | 1.77% | 19 |
|